Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial.
Jose Antonio Robles-ZuritaAndrew BriggsDikshyanta RanaZahidul QuayyumKeith G OldroydUwe ZeymerSteffen DeschSuzanne de Waha-ThieleHolger ThielePublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)
The estimates of cost-effectiveness for CO-PCI vs. MV-PCI have been shown to change depending on the time horizon and type of economic evaluation performed. The results favoured a long-term horizon analysis for avoiding underestimation of QALY gains from the CO-PCI arm.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- left ventricular
- atrial fibrillation
- coronary artery bypass
- heart failure
- clinical trial
- study protocol
- phase ii